171 related articles for article (PubMed ID: 23589544)
1. Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.
Buettner R; Wolf J; Thomas RK
J Clin Oncol; 2013 May; 31(15):1858-65. PubMed ID: 23589544
[TBL] [Abstract][Full Text] [Related]
2. Precision oncology: an overview.
Garraway LA; Verweij J; Ballman KV
J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
[No Abstract] [Full Text] [Related]
3. Genomics driven-oncology: challenges and perspectives.
Normanno N; Cree IA
BMC Cancer; 2015 Mar; 15():141. PubMed ID: 25884512
[TBL] [Abstract][Full Text] [Related]
4. Genomic medicine frontier in human solid tumors: prospects and challenges.
Dienstmann R; Rodon J; Barretina J; Tabernero J
J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
[TBL] [Abstract][Full Text] [Related]
5. Oncologists push beyond new lung cancer genomic testing guidelines.
Garber K
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25677038
[No Abstract] [Full Text] [Related]
6. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
[TBL] [Abstract][Full Text] [Related]
7. Genetic basis for susceptibility to lung cancer: Recent progress and future directions.
Yokota J; Shiraishi K; Kohno T
Adv Cancer Res; 2010; 109():51-72. PubMed ID: 21070914
[TBL] [Abstract][Full Text] [Related]
8. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
9. [Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].
Brückl W
Dtsch Med Wochenschr; 2012 Mar; 137(12):592. PubMed ID: 22415622
[No Abstract] [Full Text] [Related]
10. [Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Contra].
von Pawel J
Dtsch Med Wochenschr; 2012 Mar; 137(12):593. PubMed ID: 22415623
[No Abstract] [Full Text] [Related]
11. Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation.
Fukumoto K; Usami N; Okasaka T; Kawaguchi K; Okagawa T; Suzuki H; Yokoi K
Lung Cancer; 2011 Nov; 74(2):352-3. PubMed ID: 21944773
[TBL] [Abstract][Full Text] [Related]
12. Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.
Hasanovic A; Ang D; Moreira AL; Zakowski MF
Lung Cancer; 2012 Aug; 77(2):299-305. PubMed ID: 22542171
[TBL] [Abstract][Full Text] [Related]
13. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations.
Garcia-Olivé I; Monsó E; Andreo F; Sanz-Santos J; Taron M; Molina-Vila MA; Llatjós M; Castellà E; Moran T; Bertran-Alamillo J; Mayo-de-Las-Casas C; Queralt C; Rosell R
Eur Respir J; 2010 Feb; 35(2):391-5. PubMed ID: 19643949
[TBL] [Abstract][Full Text] [Related]
14. Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma.
Wu SG; Gow CH; Yu CJ; Chang YL; Yang CH; Hsu YC; Shih JY; Lee YC; Yang PC
Eur Respir J; 2008 Oct; 32(4):924-30. PubMed ID: 18508816
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.
Taniguchi K; Uchida J; Nishino K; Kumagai T; Okuyama T; Okami J; Higashiyama M; Kodama K; Imamura F; Kato K
Clin Cancer Res; 2011 Dec; 17(24):7808-15. PubMed ID: 21976538
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
Yamada T; Matsumoto K; Wang W; Li Q; Nishioka Y; Sekido Y; Sone S; Yano S
Clin Cancer Res; 2010 Jan; 16(1):174-83. PubMed ID: 20008840
[TBL] [Abstract][Full Text] [Related]
17. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications.
Prudkin L; Wistuba II
Ann Diagn Pathol; 2006 Oct; 10(5):306-15. PubMed ID: 16979526
[TBL] [Abstract][Full Text] [Related]
19. Genomic approaches to lung cancer.
Thomas RK; Weir B; Meyerson M
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4384s-4391s. PubMed ID: 16857815
[TBL] [Abstract][Full Text] [Related]
20. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
